Kalbe Farma Tbk PT (KLBF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp956.75 Billion ≈ $56.06 Million USD) by net assets (Rp24.19 Trillion ≈ $1.42 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Kalbe Farma Tbk PT - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Kalbe Farma Tbk PT debt and liabilities for a breakdown of total debt and financial obligations.
Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Slide Insurance Holdings, Inc. Common Stock
NASDAQ:SLDE
|
0.026x |
|
Jiangsu Cnano Technology Co Ltd
SHG:688116
|
0.025x |
|
ZTE Corporation
F:FZM
|
0.038x |
|
Kayne Anderson MLP Investment Closed Fund
NYSE:KYN
|
0.012x |
|
The Andersons Inc
NASDAQ:ANDE
|
-0.005x |
|
Krungthai Card Public Company Limited
BK:KTC-R
|
-0.012x |
|
Mister Car Wash, Inc. Common Stock
NASDAQ:MCW
|
0.095x |
|
ARIS MNG.CORP.
F:ZP1
|
N/A |
Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2024)
The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Kalbe Farma Tbk PT.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp24.59 Trillion ≈ $1.44 Billion |
Rp4.79 Trillion ≈ $280.39 Million |
0.195x | +54.74% |
| 2023-12-31 | Rp23.12 Trillion ≈ $1.35 Billion |
Rp2.91 Trillion ≈ $170.37 Million |
0.126x | -26.28% |
| 2022-12-31 | Rp22.10 Trillion ≈ $1.29 Billion |
Rp3.77 Trillion ≈ $220.87 Million |
0.171x | +28.37% |
| 2021-12-31 | Rp21.27 Trillion ≈ $1.25 Billion |
Rp2.83 Trillion ≈ $165.59 Million |
0.133x | -42.38% |
| 2020-12-31 | Rp18.28 Trillion ≈ $1.07 Billion |
Rp4.21 Trillion ≈ $246.97 Million |
0.231x | +53.92% |
| 2019-12-31 | Rp16.71 Trillion ≈ $978.88 Million |
Rp2.50 Trillion ≈ $146.66 Million |
0.150x | -17.30% |
| 2018-12-31 | Rp15.29 Trillion ≈ $896.20 Million |
Rp2.77 Trillion ≈ $162.36 Million |
0.181x | +25.33% |
| 2017-12-31 | Rp13.89 Trillion ≈ $814.14 Million |
Rp2.01 Trillion ≈ $117.68 Million |
0.145x | -16.59% |
| 2016-12-31 | Rp12.46 Trillion ≈ $730.33 Million |
Rp2.16 Trillion ≈ $126.56 Million |
0.173x | -22.85% |
| 2015-12-31 | Rp10.94 Trillion ≈ $640.94 Million |
Rp2.46 Trillion ≈ $143.97 Million |
0.225x | -4.79% |
| 2014-12-31 | Rp9.82 Trillion ≈ $575.27 Million |
Rp2.32 Trillion ≈ $135.72 Million |
0.236x | +116.28% |
| 2013-12-31 | Rp8.50 Trillion ≈ $498.06 Million |
Rp927.16 Billion ≈ $54.33 Million |
0.109x | -41.58% |
| 2012-12-31 | Rp7.37 Trillion ≈ $431.95 Million |
Rp1.38 Trillion ≈ $80.65 Million |
0.187x | -17.44% |
| 2011-12-31 | Rp6.52 Trillion ≈ $381.81 Million |
Rp1.47 Trillion ≈ $86.34 Million |
0.226x | +13.15% |
| 2010-12-31 | Rp5.77 Trillion ≈ $338.21 Million |
Rp1.15 Trillion ≈ $67.60 Million |
0.200x | -29.78% |
| 2009-12-31 | Rp4.79 Trillion ≈ $280.71 Million |
Rp1.36 Trillion ≈ $79.90 Million |
0.285x | +53.10% |
| 2008-12-31 | Rp4.34 Trillion ≈ $254.57 Million |
Rp807.70 Billion ≈ $47.33 Million |
0.186x | +105.77% |
| 2007-12-31 | Rp4.02 Trillion ≈ $235.36 Million |
Rp362.90 Billion ≈ $21.26 Million |
0.090x | -50.02% |
| 2006-12-31 | Rp3.54 Trillion ≈ $207.67 Million |
Rp640.61 Billion ≈ $37.54 Million |
0.181x | +15.14% |
| 2005-12-31 | Rp2.81 Trillion ≈ $164.74 Million |
Rp441.37 Billion ≈ $25.86 Million |
0.157x | -45.36% |
| 2004-12-31 | Rp1.48 Trillion ≈ $86.69 Million |
Rp425.07 Billion ≈ $24.91 Million |
0.287x | -42.02% |
| 2003-12-31 | Rp1.02 Trillion ≈ $59.97 Million |
Rp507.17 Billion ≈ $29.72 Million |
0.496x | -19.13% |
| 2002-12-31 | Rp651.41 Billion ≈ $38.17 Million |
Rp399.13 Billion ≈ $23.39 Million |
0.613x | +25.47% |
| 2001-12-31 | Rp345.97 Billion ≈ $20.27 Million |
Rp168.95 Billion ≈ $9.90 Million |
0.488x | +52.08% |
| 2000-12-31 | Rp305.74 Billion ≈ $17.91 Million |
Rp98.17 Billion ≈ $5.75 Million |
0.321x | -- |
About Kalbe Farma Tbk PT
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biop… Read more